Medlab Clinical Ltd (ASX:MDC)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MDC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MDC

  • Market CapAUD0.000m
  • SymbolASX:MDC
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINAU000000MDC8

Company Profile

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.Medlab Clinical Ltd is an Australia-based medical research and development company. The principal activities of the group are the sale of nutraceutical products and pharmaceutical research.

Latest MDC news

Currently there for this company. Visit our news hub for other news .